BioTime Inc.

(LCTX)

By |

Profile

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. BioTime's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for acute spinal cord injuries and VAC2, a allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer. Its lead cell delivery clinical program is Renevia, an investigational medical device developed as an alternative for whole adipose tissue transfer procedures.

Contact Information

Website: www.lineagecell.com
Email: ir@biotimeinc.com
Main Phone: +1 510 871-4188
Address: 2173 Salk Avenue
Address 2: Suite 200
State: CA
City / Town: Carlsbad
Country: USA
Postal Code: 92008

Issuer Information

Exchange: AMX
CEO: Brian M. Culley
Employees: 79
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News



Gathering Data... Please wait

Profile

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. BioTime's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for acute spinal cord injuries and VAC2, a allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer. Its lead cell delivery clinical program is Renevia, an investigational medical device developed as an alternative for whole adipose tissue transfer procedures.

Contact Information

Website: www.lineagecell.com
Email: ir@biotimeinc.com
Main Phone: +1 510 871-4188
Address: 2173 Salk Avenue
Address 2: Suite 200
State: CA
City / Town: Carlsbad
Country: USA
Postal Code: 92008

Issuer Information

Exchange: AMX
CEO: Brian M. Culley
Employees: 79
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

$ 0.98 $ 0.0178 (1.85%)
Last Price 0.98 Change $ 0.0178 Change % 1.85 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.93 High 0.99 Low 0.93 Prev Close 0.96
Last Trade Volume 309,465 52 Wk Hi 2.15 52 Wk Low 0.66
Market Cap 146.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 149,642,861.00 EPS (TTM) 0.28 PE Ratio 3.30 Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 22
Number of Buys 4 16
Number of Sells 0 6
Net Activity 60000 2727603
Last 10 Buys Shares
Brian M. Culley 1,000
Chase C. Leavitt 1,000
Brandi L. Roberts 1,000
Deborah Andrews 1,000
Russell L. Skibsted 1,000
Michael D. West 1,000
Neal C. Bradsher 1,000
Neal C. Bradsher 1,000
Aditya Mohanty 1,000
Stephana Patton 1,000
Last 10 Sell Shares
Alfred D. Kingsley 1,000
Alfred D. Kingsley 1,000
Alfred D. Kingsley 1,000
Michael D. West 1,000
Robert W. Peabody 1,000
William P. Tew 1,000
William P. Tew 1,000
William P. Tew 1,000
Alfred D. Kingsley 1,000
Alfred D. Kingsley 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 6
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 4.4 4.4 4.4 4.4
Standard Deviation 1.52 1.52 1.52 1.52
Date of Most Recent Estimate 07/11/19 07/11/19 07/11/19 08/12/19
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.33 1